Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · IEX Real-Time Price · USD
0.760
-0.200 (-20.83%)
At close: Jul 26, 2024, 2:04 PM
0.800
+0.040 (5.26%)
After-hours: Jul 26, 2024, 7:08 PM EDT
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.03 million as of July 26, 2024. Its market cap has decreased by -15.43% in one year.
Market Cap
2.03M
Enterprise Value
5.55M
1-Year Change
-15.43%
Ranking
Category
Stock Price
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.03M, a decrease of -95.87%. That is a compound annual growth rate of -33.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.40M | -14.29% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 2.60M |
| Virax Biolabs Group | 2.60M |
| FOXO Technologies | 2.54M |
| Aclarion | 2.51M |
| Heart Test Laboratories | 2.50M |
| Cyclacel Pharmaceuticals | 2.46M |
| cbdMD | 2.43M |
| Helius Medical Technologies | 2.39M |